Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00267
|
|||||
| Drug Name |
Indomethacin
|
|||||
| Synonyms |
Aconip; Aconip (TN); Amuno; Apo-Indomethacin; Arthrexin; Artracin; Artrinovo; Artrivia; Bonidin; Bonidon; Bonidon Gel; Catlep; Chibro-amuno; Chrono-indicid; Chrono-indocid; Confortid; DESMETHYL INDOMETHACIN; Dolcidium; Dolcidium PL;Flexin continus; Dolovin; Durametacin; Elmetacin; Hicin; I 7378; IMN; IN1454; Idomethine; Imbrilon; Inacid; Indacin; Indameth; Indmethacine; Indo-Lemmon; Indo-Spray; Indo-phlogont; Indo-rectolmin; Indo-tablinen; Indochron E-R (TN); Indocid; Indocid (TN); Indocid (pharmaceutical); Indocid Pda; Indocid Sr; Indocin; Indocin (TN); Indocin I.V; Indocin I.V.; Indocin Sr; Indocin-SR (TN); Indolar SR; Indomecol; Indomed; Indomee; Indomet 140; Indometacin; Indometacin (JP15/INN); Indometacina; Indometacina [INN-Spanish]; Indometacine; Indometacine [INN-French]; Indometacinum; Indometacinum [INN-Latin]; Indometacyna; Indometacyna [Polish]; Indomethacin & MAP-30; Indomethacin (USP); Indomethacin [USAN:BAN]; Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin; Indomethacine; Indomethacinum; Indomethancin; Indomethazine; Indomethegan; Indomethine; Indometicina; Indometicina [Spanish]; Indomo; Indomod; Indoptic; Indoptol; Indorektal; Indoxen; Inflazon; Infrocin; Inteban sp; Lausit; Liometacen; Metacen; Metartril; Methazine; Metindol; Mezolin; Miametan; Mikametan; Mobilan; Novo-Methacin; Novomethacin; Reumacide; Rhemacin LA; Rheumacin LA; Sadoreum; Tannex; Vonum
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Moderate to severe rheumatoid arthritis [ICD11: FA20] | Approved | [1] | |||
| Therapeutic Class |
Antiinflammatory Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H16ClNO4
|
|||||
| Canonical SMILES |
CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
|
|||||
| InChI |
InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
|
|||||
| InChIKey |
CGIGDMFJXJATDK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 53-86-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 357.8 | Topological Polar Surface Area | 68.5 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
4.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321568
, 10525985
, 11111328
, 11111329
, 11113361
, 11121750
, 11122230
, 11335446
, 11360685
, 11362903
, 11363813
, 11365465
, 11366375
, 11368027
, 11368937
, 11370997
, 11370998
, 11371496
, 11373534
, 11373628
, 11376189
, 11377099
, 11404374
, 11446060
, 11461657
, 11466300
, 11467420
, 11484715
, 11486099
, 11488786
, 11490284
, 11491833
, 11494733
, 3225554
, 5032
, 5208606
, 611045
, 612102
, 6435989
, 7847209
, 7888379
, 7979604
, 8027945
, 8027950
, 8027958
, 8149387
, 8152346
, 832223
, 841055
, 856012
|
|||||
| ChEBI ID |
ChEBI:49662
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Indomethacin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1. Br J Cancer. 2007 Oct 22;97(8):1077-83. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.